JAGX CIK: 1585608

Jaguar Health, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
28.4
FY22:
22.3
FY23:
28.0
FY24:
32.2
FY25:
20.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
24.8
FY22:
25.1
FY23:
22.8
FY24:
21.2
FY25:
18.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
53.3
FY22:
47.5
FY23:
50.8
FY24:
53.4
FY25:
38.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
15.5
FY22:
30.3
FY23:
14.0
FY24:
19.7
FY25:
40.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
25.9
FY22:
18.5
FY23:
31.9
FY24:
24.7
FY25:
16.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.9
FY22:
−1.36
FY23:
4.90
FY24:
6.49
FY25:
−18.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
53.3
FY22:
47.5
FY23:
50.8
FY24:
–
FY25:
38.3

All amounts in millions USD Data source:SEC EDGAR